A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model
S. Prakash, N. R. Dhanushkodi, M. Singer, A. Quadiri, L. Zayou, H. Vahed, P.-G. Coulon, A. El Babsiri, D. Gil, J. B. Ulmer, L. BENMOHAMED
This paper develops a multi-antigen mRNA/LNP-based pan-CoV vaccine that provides cross-protective immunity against multiple SARS-CoV-2 variants in a hamster model.
bioRxiv · Feb 14, 2024 · PreprintImmunology